ÂÜÀòÂÒÂ×

Kevin Zikaras is an accomplished professional in clinical development operations with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Clinical Development Operations at Convergent Therapeutics, Inc. since 2023, Kevin previously held the same title at TCR² Therapeutics Inc. from 2018 to 2023, where Kevin contributed significantly to building various clinical functions. Prior roles include Director of Clinical Development at Actinium Pharmaceuticals, Inc., Clinical Protocol Manager at Bristol-Myers Squibb, Clinical Research Manager at Columbia University Irving Medical Center, and Research Study Specialist at Memorial Sloan Kettering Cancer Center. Kevin holds an MBA from Cornell Johnson Graduate School of Management, an MS in Policy and Research - Healthcare Leadership from Weill Cornell Graduate School of Medical Sciences, an MS in Strategic Regulatory Affairs from Northeastern University, and a BA in Biology and Sociology from Bowdoin College.